WallStreetZenWallStreetZen

NASDAQ: RPRX
Royalty Pharma PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for RPRX

Based on 4 analysts offering 12 month price targets for Royalty Pharma PLC.
Min Forecast
$38.00+36.59%
Avg Forecast
$46.75+68.04%
Max Forecast
$57.00+104.89%

Should I buy or sell RPRX stock?

Based on 4 analysts offering ratings for Royalty Pharma PLC.
Strong Buy
Strong Buy
4 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RPRX stock forecasts and price targets.

RPRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-12
lockedlocked$00.00+00.00%2024-02-20
lockedlocked$00.00+00.00%2024-02-20
lockedlocked$00.00+00.00%2023-11-09

1 of 1

Forecast return on equity

Is RPRX forecast to generate an efficient return?
Company
N/A
Industry
-71.71%
Market
19.68%

Forecast return on assets

Is RPRX forecast to generate an efficient return on assets?
Company
N/A
Industry
7.14%

RPRX revenue forecast

What is RPRX's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$2.7B+13.53%
Avg 2 year Forecast
$2.9B+24.06%
Avg 3 year Forecast
$3.2B+34.09%
RPRX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RPRX earnings growth forecast

How is RPRX forecast to perform vs Biotechnology companies and vs the US market?
Company
34.87%
Industry
6.81%
Market
28.56%
RPRX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
RPRX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
RPRX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

RPRX revenue growth forecast

How is RPRX forecast to perform vs Biotechnology companies and vs the US market?
Company
11.31%
Industry
59.36%
Market
9.3%
RPRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RPRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RPRX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RPRX$27.82$46.75+68.04%Strong Buy
BMRN$92.06$103.44+12.37%Strong Buy
ALNY$146.07$213.58+46.22%Buy
BGNE$138.99$244.25+75.73%Strong Buy
GMAB$28.56$45.00+57.56%Buy
View Top Biotech Stocks

Royalty Pharma Stock Forecast FAQ

Is Royalty Pharma Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: RPRX) stock is to Strong Buy RPRX stock.

Out of 4 analysts, 4 (100%) are recommending RPRX as a Strong Buy, 0 (0%) are recommending RPRX as a Buy, 0 (0%) are recommending RPRX as a Hold, 0 (0%) are recommending RPRX as a Sell, and 0 (0%) are recommending RPRX as a Strong Sell.

If you're new to stock investing, here's how to buy Royalty Pharma stock.

What is RPRX's revenue growth forecast for 2024-2026?

(NASDAQ: RPRX) Royalty Pharma's forecast annual revenue growth rate of 11.31% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 59.36%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.3%.

Royalty Pharma's revenue in 2024 is $2,354,554,000.On average, 2 Wall Street analysts forecast RPRX's revenue for 2024 to be $1,597,034,603,866, with the lowest RPRX revenue forecast at $1,565,022,255,460, and the highest RPRX revenue forecast at $1,629,046,952,272. On average, 2 Wall Street analysts forecast RPRX's revenue for 2025 to be $1,745,101,050,163, with the lowest RPRX revenue forecast at $1,710,437,883,589, and the highest RPRX revenue forecast at $1,779,764,814,172.

In 2026, RPRX is forecast to generate $1,886,235,460,580 in revenue, with the lowest revenue forecast at $1,866,643,184,044 and the highest revenue forecast at $1,905,828,334,551.

What is RPRX's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: RPRX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 7.14%.

What is RPRX's Price Target?

According to 4 Wall Street analysts that have issued a 1 year RPRX price target, the average RPRX price target is $46.75, with the highest RPRX stock price forecast at $57.00 and the lowest RPRX stock price forecast at $38.00.

On average, Wall Street analysts predict that Royalty Pharma's share price could reach $46.75 by Apr 12, 2025. The average Royalty Pharma stock price prediction forecasts a potential upside of 68.04% from the current RPRX share price of $27.82.

What is RPRX's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: RPRX) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.